Supriya Lifescience Limited
Supriya Lifescience Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1997, the company has established itself as a leader in the production of active pharmaceutical ingredients (APIs) and intermediates, catering to both domestic and international markets. With a strong focus on quality and innovation, Supriya Lifescience offers a diverse range of products, including anti-allergic, anti-inflammatory, and anti-viral APIs. Their commitment to research and development has led to significant advancements, positioning them as a trusted supplier in the global pharmaceutical landscape. Notably, the company has achieved several milestones, including regulatory approvals from major international health authorities, further solidifying its reputation for excellence in the industry.
DitchCarbon Score
How does Supriya Lifescience Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Supriya Lifescience Limited's score of 6 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Supriya Lifescience Limited's reported carbon emissions
In 2023, Supriya Lifescience Limited reported total carbon emissions of approximately 11,450,770 kg CO2e from Scope 2 and about 490,206 kg CO2e from Scope 1, resulting in a combined total of approximately 11,940,976 kg CO2e. This represents an increase in emissions compared to 2022, where the company recorded about 8,643,810 kg CO2e from Scope 2 and approximately 315,257 kg CO2e from Scope 1, totalling around 8,959,067 kg CO2e. For 2024, the company reported approximately 10,995,310 kg CO2e from Scope 2 and about 451,010 kg CO2e from Scope 1, indicating a slight decrease in total emissions to around 11,446,320 kg CO2e. Supriya Lifescience has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company continues to monitor its emissions, focusing on improving its emission intensity per unit of revenue, which was approximately 0.173 kg CO2e per USD in 2023. Overall, while Supriya Lifescience Limited has shown fluctuations in its carbon emissions, it has yet to establish formal reduction commitments or targets.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 315,257 | 000,000 | 000,000 |
| Scope 2 | 8,643,810 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Supriya Lifescience Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
